Desq Long
Sign in

Company

Stoke Therapeutics, Inc.

STOK · CIK 0001623526

SEC FORM 4
$120,369.84

Stoke Therapeutics, Inc. (STOK)

Sale of 3,945 shares at $30.5120 per share.

Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001780088-26-000021 · filed 2026-09-03 · View filing →

SEC FORM 4
$49,691.04

Stoke Therapeutics, Inc. (STOK)

Sale of 1,600 shares at $31.0569 per share.

Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001780088-26-000021 · filed 2026-09-03 · View filing →

SEC FORM 4
$381,845.90

Stoke Therapeutics, Inc. (STOK)

Sale of 11,930 shares at $32.0072 per share.

Reporting Person Kaye Edward M. MD · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001522780-26-000007 · filed 2026-08-18 · View filing →

SEC FORM 4
$20,682.18

Stoke Therapeutics, Inc. (STOK)

Sale of 637 shares at $32.4681 per share.

Reporting Person Kaye Edward M. MD · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001522780-26-000007 · filed 2026-08-18 · View filing →

SEC FORM 4
$144,832.58

Stoke Therapeutics, Inc. (STOK)

Sale of 4,525 shares at $32.0072 per share.

Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001780088-26-000019 · filed 2026-08-18 · View filing →

SEC FORM 4
$7,857.28

Stoke Therapeutics, Inc. (STOK)

Sale of 242 shares at $32.4681 per share.

Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001780088-26-000019 · filed 2026-08-18 · View filing →

SEC FORM 4
$86,931.56

Stoke Therapeutics, Inc. (STOK)

Sale of 2,716 shares at $32.0072 per share.

Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001966716-26-000012 · filed 2026-08-18 · View filing →

SEC FORM 4
$4,707.87

Stoke Therapeutics, Inc. (STOK)

Sale of 145 shares at $32.4681 per share.

Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001966716-26-000012 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

Stoke Therapeutics, Inc. (STOK)

Acquisition (code M) of 26,250 shares at $0 per share.

Reporting Person Kaye Edward M. MD · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001522780-26-000007 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

Stoke Therapeutics, Inc. (STOK)

Acquisition (code M) of 10,000 shares at $0 per share.

Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001780088-26-000019 · filed 2026-08-18 · View filing →

SEC FORM 4
$0.00

Stoke Therapeutics, Inc. (STOK)

Acquisition (code M) of 6,000 shares at $0 per share.

Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001966716-26-000012 · filed 2026-08-18 · View filing →